VA to Expedite Benefits for K2 Veterans With Certain Cancers Linked to Toxic Exposure

Veterans who served at Karshi-Khanabad (K2) Air Base in Uzbekistan and subsequently developed specific malignancies may soon be eligible for expedited VA disability benefits. On Tuesday, VA Secretary Denis McDonough announced his intention to include genitourinary cancers, such as bladder and urethra malignancies, in the VA's presumptive list for K2 veterans. This move will expedite compensation for those who were affected by toxic exposures during the Global War on Terror.

‍

The VA's announcement is in response to allegations of toxic substances at K2, including depleted uranium, fuel contaminants, and chemical weapon residues. Severe disorders, such as cancers of the brain, thyroid, and pancreas, have been reported by numerous veterans who served at the base. This recent decision is a component of the VA's broader initiatives under the PACT Act, which allows it to designate conditions as presumptive without requiring additional external evaluations.

‍

McDonough reports that the VA has experienced high participation rates from K2 veterans, with nearly 12,000 of the 16,000 service members enrolled in VA healthcare and 13,002 already holding a disability classification for related conditions. Advocates, such as the Stronghold Freedom Foundation, welcomed the news as a substantial stride toward addressing the long-term health consequences of service at K2.

‍

"The VA's efforts to assist those impacted by K2's toxic conditions are greatly appreciated," stated Matt Erpelding, Executive Director of the Stronghold Freedom Foundation. He underscored the necessity of addressing all related health concerns.

‍

This year, the VA also observed record-high appointments and disability claim processing, which underscores its dedication to improving support for veterans and their families.

‍